Innovations

Analysis reveals adverse effects of complex cancer therapies called antibody drug conjugates

0
Research scientist with gloves holding blood sample on glass in laboratory. Biology doctor analyzing plasma dna for medical discovery in pharmaceutical industry. Science equipment on desk

Over the past two decades, numerous complex cancer therapies called antibody drug conjugates (ADCs) have been tested in clinical trials and approved for use in patients. Investigators recently performed a comprehensive analysis of multiple scientific databases to outline the potential toxicities associated with these medications. Their findings are published online in Cancer.

England vs. Iran livestream options for 2022 World Cup

Previous article

Study suggests bats are an underrecognized arenavirus reservoir

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations